Related Experiment Video
Updated: Jan 13, 2026

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
The Evolving Role of In Vitro-In Vivo Correlation in Model-Informed Drug Development: A Multi-Stakeholder Perspective
Marylore Chenel1, Sylvain Fouliard2, Emma Hansson1
1Pharmetheus AB, Uppsala, Sweden.
Abstract:
In vitro-in vivo correlation/relationship (IVIVC/R) models such as physiologically based biopharmaceutics modeling (PBBM) are crucial tools that link biopharmaceutical properties to clinical performance. They accelerate development, reduce costly experimental studies and clinical trials, and justify regulatory decisions for drug formulation related questions of interest (QOI). This paper consolidates insights from academia, industry, and service providers, exploring future opportunities, organizational challenges, regulatory perspectives, and competency gaps for further enhanced application in pharmaceutical development and regulatory decision-making.
More Related Videos
10:24Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
Published on: July 4, 2018
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
Drug Product Performance: In Vitro–In Vivo Correlation
In Vitro Drug Release Testing: Overview, Development and Validation
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Equivalence: In Vitro and In Vivo Bioequivalence
Drug Discovery: Overview
In Vitro Drug Dissolution: Compendial Testing Models I